Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability Study of CL-108 vs Reference Treatments in Healthy Subjects
NCT02465866Phase 1Completed
- Sponsor
- Charleston Laboratories, Inc.
- Start
- Nov 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of hydrocodone + acetaminophen + promethazine in pain and Opioid-induced nausea and vomiting (OINV) (4 arms), sponsored by Charleston Laboratories, Inc. Primary endpoints: Maximum Drug Concentration in Plasma, Time to Reach Maximum Concentration and 8 more. Started Nov 2014; status: completed.
02
Drugs
hydrocodone + acetaminophen + promethazine
03
Conditions
painOpioid-induced nausea and vomiting (OINV)
Beyond the preview
Go deeper on NCT02465866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02465866.